ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting Autophagy

Pan, Zihao; Zheng, Jun; Zhang, Jiebin; Lin, Jiatong; Lai, Jianguo; Lyu, Zejian; Feng, Huolun; Wang, Junjiang*; Wu, Deqing*; Li, Yong*广东省人民医院; 南方医科大学; 中山大学; y
Advanced Science2022-12DOI: 10.1002/advs.202204513
26被引16阅读
引用收藏
分享

摘要

Oxaliplatin is commonly used in chemotherapeutic regimens for colorectal cancer (CRC) after surgical resection. However, acquired chemoresistance seriously affects the curative effect in CRC patients, and the mechanism is still unclear. Here, a circular RNA, circATG4B is identified, which plays an important role in oxaliplatin resistance in CRC. circATG4B expression is found to be increased in exosomes secreted by oxaliplatin-resistant CRC cells. In addition, the results suggest that circATG4B induces oxaliplatin resistance by promoting autophagy. Further in vivo and in vitro studies indicate that the effect of circATG4B is attributed to its potential to encode a novel protein, circATG4B-222aa. Next, circATG4B-222aa is found to function as a decoy to competitively interact with TMED10 and prevent TMED10 from binding to ATG4B, which leads to increased autophagy followed by induction of chemoresistance. Therefore, this study reveals that exosomal circATG4B participates in the decreased chemosensitivity of CRC cells, providing a new rationale for a potential therapeutic target for oxaliplatin resistance in CRC.

学科与关键词

关键词
autophagychemoresistancecircular RNAcolorectal cancer (CRC)
相关
加载中…
  • CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer
    Zhu, Sixian; Mao, Jie; Zhang, Xiaoli; Wang, Ping; Zhou, Yi; Tong, Jin; Peng, Hui; Yang, Bei; Fu, Qiang*Digestive and Liver Disease, 2024, 56(2): 330-342.被引 4
  • Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
    Zhou, Yue; Zhang, Qing; Wang, Minjia; Huang, Chengzhi*; Yao, Xueqing*Frontiers in Oncology, 2022, 12: 827891.被引 5
  • WBSCR22 confers oxaliplatin resistance in human colorectal cancer
    Yan Dongmei; Tu Linglan; Yuan Haining; Fang Jianfei; Cheng Liyan; Zheng Xiaoliang; Wang XiaojuScientific Reports, 2017, 7: 15443.
查看全部 →

发表信息

论文状态
公开发表
期刊
Advanced Science
发表日期
2022-12
卷期
第 9 卷, 第 35 期
DOI
10.1002/advs.202204513
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82002508, 82002928, 81900597, 82073171]; Natural Science Foundation of Guangdong Province, China [2021A1515012136]; Science and Technology Program Guangzhou [201904010020, 202102080038, 202201010898]; National key Clinical Specialty Construction Project [2022YW030009]; Excellent Young Talent Program of Guangdong Provincial People's Hospital [KY012021186]; GDPH supporting Funding for NSFC Program [KY012021159]

作者

  • P

    Pan, Zihao (第一作者)

    guangdong prov peoples hosp · 2 · southern med univ

  • Z

    Zheng, Jun

    sun yat sen univ

查看全部 10 位作者收起作者
  • Z

    Zhang, Jiebin

    sun yat sen univ

  • L

    Lin, Jiatong

    guangdong prov peoples hosp

  • L

    Lai, Jianguo

    guangdong prov peoples hosp

  • L

    Lyu, Zejian

    2 · southern med univ · guangdong prov peoples hosp

  • F

    Feng, Huolun

    guangdong prov peoples hosp

  • W

    Wang, Junjiang (通讯)

    2 · southern med univ · guangdong prov peoples hosp

  • W

    Wu, Deqing (通讯)

    2 · southern med univ · guangdong prov peoples hosp

  • L

    Li, Yong (通讯)

    2 · southern med univ · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417